Unnecessary use of fluoroquinolone antibiotics in hospitalized patients
Open Access
- 5 July 2011
- journal article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 11 (1), 187-7
- https://doi.org/10.1186/1471-2334-11-187
Abstract
Fluoroquinolones are among the most commonly prescribed antimicrobials and are an important risk factor for colonization and infection with fluoroquinolone-resistant gram-negative bacilli and for Clostridium difficile infection (CDI). In this study, our aim was to determine current patterns of inappropriate fluoroquinolone prescribing among hospitalized patients, and to test the hypothesis that longer than necessary treatment durations account for a significant proportion of unnecessary fluoroquinolone use. We conducted a 6-week prospective, observational study to determine the frequency of, reasons for, and adverse effects associated with unnecessary fluoroquinolone use in a tertiary-care academic medical center. For randomly-selected adult inpatients receiving fluoroquinolones, therapy was determined to be necessary or unnecessary based on published guidelines or standard principles of infectious diseases. Adverse effects were determined based on chart review 6 weeks after completion of therapy. Of 1,773 days of fluoroquinolone therapy, 690 (39%) were deemed unnecessary. The most common reasons for unnecessary therapy included administration of antimicrobials for non-infectious or non-bacterial syndromes (292 days-of-therapy) and administration of antimicrobials for longer than necessary durations (234 days-of-therapy). The most common syndrome associated with unnecessary therapy was urinary tract infection or asymptomatic bacteriuria (30% of all unnecessary days-of-therapy). Twenty-seven percent (60/227) of regimens were associated with adverse effects possibly attributable to therapy, including gastrointestinal adverse effects (14% of regimens), colonization by resistant pathogens (8% of regimens), and CDI (4% of regimens). In our institution, 39% of all days of fluoroquinolone therapy were unnecessary. Interventions that focus on improving adherence with current guidelines for duration of antimicrobial therapy and for management of urinary syndromes could significantly reduce overuse of fluoroquinolones.Keywords
This publication has 20 references indexed in Scilit:
- Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unitJournal of Hospital Infection, 2005
- “Collateral Damage” from Cephalosporin or Quinolone Antibiotic TherapyClinical Infectious Diseases, 2004
- Unnecessary Use of Antimicrobials in Hospitalized PatientsArchives of Internal Medicine, 2003
- Antibiotic Resistance Among Gram-Negative Bacilli in US Intensive Care UnitsJama-Journal Of The American Medical Association, 2003
- Levofloxacin use at an academic teaching institution.American Journal of Health-System Pharmacy, 2000
- Does Eradicating Bacteriuria Affect the Severity of Chronic Urinary Incontinence in Nursing Home Residents?Annals of Internal Medicine, 1995
- Does Asymptomatic Bacteriuria Predict Mortality and Does Antimicrobial Treatment Reduce Mortality in Elderly Ambulatory Women?Annals of Internal Medicine, 1994
- DUE of ciprofloxacin in the treatment of urinary tract infections in hospitalized patients.1992
- Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly womenAmerican Journal Of Medicine, 1987
- Bacteriuria in Elderly Institutionalized MenNew England Journal of Medicine, 1983